Actual risk of using very aged donors for unselected liver transplant candidates: A European single-center experience in the meld era

Annals of Surgery

Volumn 265, Issue 2, 2017, Pages 388-396

  Bertuzzo, Valentina Rosa ^a   Cescon, Matteo ^a   Odaldi, Federica ^a   Laudo, Marco Di ^a   Cucchetti, Alessandro ^a   Ravaioli, Matteo ^a   Gaudio, Massimo Del ^a   Ercolani, Giorgio ^a   D'Errico, Antonietta ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Donor age; Liver biopsy; Liver transplantation; Short ischemia time

Indexed keywords

NORADRENALIN; PROSTAGLANDIN E1;

ADULT; AGE; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; BALANCE OF RISK SCORE; BILIARY TRACT DISEASE; BODY MASS; CANCER SURGERY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHOLESTATIC HEPATITIS; CHRONIC KIDNEY FAILURE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DONOR; ERYTHROCYTE TRANSFUSION; FATTY LIVER; FEMALE; FOLLOW UP; FULMINANT HEPATIC FAILURE; GENDER; GRAFT FAILURE; GRAFT MACROSTEATOSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART ARREST; HEPATITIS C; HEPATORENAL SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION; KIDNEY DISEASE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTIPLE ORGAN FAILURE; OPERATION DURATION; OUTCOME ASSESSMENT; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; POSTNECROTIC CIRRHOSIS; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RETRANSPLANTATION; RISK ASSESSMENT; SEROLOGY; SURGICAL RISK; VERY OLD DONOR; DONOR SELECTION; END STAGE LIVER DISEASE; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RETROSPECTIVE STUDY; RISK; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; DONOR SELECTION; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84960158382     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001681     Document Type: Article

References (50)

1. Dutkowski P, Linecker M, De Oliveira ML, et al. Challenges to liver transplantation and strategies to improve outcomes. Gastroenterology. 2015; 148:307-323.
2. Cescon M, Grazi GL, Ercolani G, et al Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable? Liver Transpl. 2003; 9:1174-1180.
3. Nardo B, Masetti M, Urbani L., et al. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant. 2004; 4:1139-1147.
4. Cuende N, Miranda B, Cañón JF, et al. Donor characteristics associated with liver graft survival. Transplantation. 2005; 79:1445-1452.
5. Gastaca M, Valdivieso A, Pjoan J., et al. Donors older than 70 years in liver transplantation. Transplant Proc. 2005; 37:3851-3854.
6. Renz JF, Kin C, Kinkhabwala M., et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg. 2005; 242:556-565.
7. Cescon M, Grazi GL, Cucchetti A, et al Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl. 2008; 14:672-679.
8. Anderson CD, Vachharajani N, Doyle M., et al. Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg. 2008; 207:847-852.
9. Ravaioli M, Grazi GL, Cescon M, et al Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl Int. 2009; 22:423-433.
10. Kim DY, Moon J, Island E.R., et al. Liver transplantation using elderly donors: a risk factor analysis. Clin Transplant. 2011; 25:270-276.
11. Martins PN, Chang S, Mahadevapa B., et al. Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury. HPB. 2011; 13:212-220.
12. Darius T, Monbaliu D, Jochmans I., et al. Septuagenarians and octogenarian donors provide excellent liver grafts for transplantation. Transplant Proc. 2012; 44:2861-2867.
13. Jimenez-Romero C., Clemares-Lama M, Manrique-Municio A, et al. Longterm results using old liver grafts for transplantation: sexagenarian versus liver donors older than 70 years. World J Surg. 2013; 37:2211-2221.
14. Franco CC, Martinez JMA, Bellido CB, et al Results of liver transplants from donors aged 70 plus: analysis of Andalusian transplant register. Transplant Proc. 2013; 45:3647-3649.
15. Ghinolfi D, Marti J, De Simone P, et al. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transpl. 2014; 14:2062-2071.
16. Chedid MF, Rosen CB, Nyberg S.L., et al. Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB. 2014; 16:852-858.
17. Segev DL, Maley WR, Simpkins C.E., et al. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology. 2007; 46:1907-1918.
18. Rana A, Hardy MA, Halazun K.J., et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008; 8:2537-2546.
19. Halldorson JB, Bakthavatsalam R, Fix O., et al. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009; 9:318-326.
20. Avolio AW, Cillo U, Salizzoni M., et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant. 2011; 11:2724-2736.
21. Dutkowski P, Oberkofler CE, Slankamenac K, et al Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg. 2011; 254:745-753.
22. Weismüller T.J., Fikatas P, Schmidt J., et al. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany: limitations of the 'sickest first'-concept. Transpl Int. 2011; 24:91-99.
23. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology. 2002; 36:202-210.
24. Serra MP, Marongiu F, Marongiu M., et al. Cell-autonomous decrease in proliferative competitiveness of the aged hepatocyte. J Hepatol. 2015; 62:1341-1348.
25. Tanemura A, Mizuno S, Wada H., et al. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg. 2012; 36:1102-1111.
26. Vagefi PA, Dodge JL, Yao F.Y., et al. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2015; 21:187-194.
27. Stieber AC, Marsh JW Jr, Starzl TE. Preservation of the retrohepatic vena cava during recipient hepatectomy for orthotopic transplantation of the liver. Surg Gynecol Obstet. 1989; 168:542-544.
28. Ravaioli M, Grazi GL, Ballardini G, et al Liver transplantation with the MELD system: a prospective study from a single European center. Am J Transplant. 2006; 6:1572-1577.
29. Ravaioli M, Grazi GL, Ercolani G, et al Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation. 2006; 81:525-530.
30. Brillanti S, Vivarelli M, De Ruvo N, et al. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl. 2002; 8:884-888.
31. Varotti G, Grazi GL, Vetrone G, et al Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant. 2005; 19:492-500.
32. Gatta A, Dante A, Del Gaudio M, et al. The use of prostaglandins in the immediate postsurgical liver transplant period. Transplant Proc. 2006; 38:1092-1095.
33. Cescon M, Grazi GL, Cucchetti A, et al Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. Liver Transplant. 2009; 15:782-789.
34. Bertuzzo VR, Cescon M, Morelli M.C., et al. Long-term antiviral treatment for recurrent hepatitis C after liver transplantation. Dig Liver Dis. 2012; 44:861-867.
35. Ravaioli M, Grazi GL, Piscaglia F, et al Liver transplantation for hepatocel-lular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant. 2008; 8:2547-2557.
36. Ishak K, Baptista A, Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22:696-699.
37. Nanni Costa A., Grossi P, Gianelli Castiglione A, et al., Italian Transplant Research Network. Quality and safety in the Italian donor evaluation process. Transplantation. 2008; 85:S52-S56.
38. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006; 6:783-790.
39. Dindo D, Demartines N, Clavien PA Classification of surgical complications-a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240:205-213.
40. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39:S1-266.
41. Hoyer DP, Paul A, Gallinat A., et al. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation. Liver Int. 2015; 35:156-163.
42. Desai NM, Mange KC, Markmann J.W., et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation. 2004; 77:99-106.
43. Li C, Wen TF, Yan L.N., et al. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol. 2012; 11:471-477.
44. Mathé Z, Paul A, Molmenti EP, et al. Liver transplantation with donors over the expected lifespan in the model for end-staged liver disease era: is Mother Nature punishing us? Liver Int. 2011; 31:1054-1061.
45. Paterno F, Wima K, Hoehn R.S., et al. Use of elderly allografts in liver transplantation. Transplantation. 2016; 100:153-158.
46. Amin MG, Wolf MP, TenBrook JA Jr, et al. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transplant. 2004; 10:1468-1475.
47. Dutkowski P, Schlegel A, De Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014; 60:765-772.
48. Guarrera JV, Henry SD, Samstein B, et al Hypothermic machine preservation facilitates successful transplantation of "orphan" extended criteria donor livers. Am J Transplant. 2015; 15:161-169.
49. Marrero JA, Fontana RJ, Lok AS Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl. 2009; 15: 1142-1148.
50. Gane EJ, Agarwal K. Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: "a flood of opportunity". Am J Transplant. 2014; 14:994-1002.